A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy Subjects
Clinical trial NCT05924321 · COMPLETED
Trial details
- NCT number
- NCT05924321
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-25
- Primary completion
- 2023-09-21
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.